Hallucination News and Research

RSS

A hallucination, in the broadest sense of the word, is a perception in the absence of a stimulus. In a stricter sense, hallucinations are defined as perceptions in a conscious and awake state in the absence of external stimuli which have qualities of real perception, in that they are vivid, substantial, and located in external objective space.

FDA approves Azilect for the treatment of Parkinson's

The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease.

17 May 2006

Olanzapine appears to lower or delay full-blown psychosis

For young people who clearly seem to be developing early signs of schizophrenia, treatment with the antipsychotic drug olanzapine appears to lower or delay the rate of conversion to full-blown psychosis, according to an article by a Yale School of Medicine researcher in the May issue of The American Journal of Psychiatry.

3 May 2006

Skin patch to treat ADHD gets the green light

The Food and Drug Administration (FDA) in the U.S. has approved a skin patch to control attention deficit hyperactivity disorder (ADHD) in children.

10 Apr 2006

Man takes 40,000 ecstasy pills in nine years

Researchers from London University have revealed details of a man who claims to have taken 40,000 ecstasy pills over nine year period.

5 Apr 2006

New guidelines for diagnosis and treatment of Parkinson disease

New guidelines developed by the American Academy of Neurology aim to educate physicians on the diagnosis and treatment of Parkinson disease and provide people with Parkinson disease an improved quality of life.

3 Apr 2006

Yale School of Medicine expands research using transcranial magnetic stimulation for schizophrenia

Yale School of Medicine researchers are recruiting patients nationally for a clinical trial using transcranial magnetic stimulation (TMS) to help still the voices that are so troubling to some persons with schizophrenia.

9 Mar 2006

Anabolic steroids flip the adolescent brain's switch for aggression

Anabolic steroids not only make teens more aggressive, but may keep them that way into young adulthood. The effect ultimately wears off but there may be other, lasting consequences for the developing brain.

27 Feb 2006

Steroids trigger long lasting aggression in teens

According to a U.S. study steroids may have a lasting effect on teenagers' brains, and could even flip the adolescent brain's switch for aggression which may last for at least two years.

27 Feb 2006

Researchers create animal model of any schizophrenic characteristics

Researchers have developed a mouse strain in which the abnormal activity of the dopamine machinery in a specific part of the brain causes cognitive and behavioral impairments mimicking those in human schizophrenics.

20 Feb 2006

Tamiflu alone won't work in bird flu pandemic

In a review published this week a warning has been issued against the apparent reliance by most countries on the drug Tamiflu to combat a bird flu pandemic.

19 Jan 2006

Drugs and electroconvulsive therapy best treatment for severe depression

According to a new study, despite the fact that over the last decade, two treatments which are often castigated in the media, and have raised both public and professional concern, antidepressants such as Prozac and Seroxat, and electroconvulsive therapy (ECT), remain the most effective treatments for moderate to severe depression.

16 Jan 2006

Alarming deaths of Tamiflu patients - FDA to investigate

The U.S. Food and Drug Administration are investigating the deaths of 12 children in Japan who took Roche's flu-fighting drug Tamiflu.

20 Nov 2005

Teenage suicides and Tamiflu - is there a link?

Roche the maker of the anti-flu drug Tamiflu has reported to authorities in Japan the possible suicides of two teenage boys although the company says there was no clear evidence that the drug had contributed to their deaths.

14 Nov 2005

Alien abduction may be all in the mind

New research presented at the Science Museum's Dana Centre, supports what scientists have long argued: that people who report contact with aliens have a psychological profile that might make them more susceptible to false memories.

27 Oct 2005

Fndings shed some light on the brain mechanisms involved in schizophrenia

Scientists have discovered that schizophrenia sufferers are not fooled by a visual illusion and are able to judge it more accurately than non-schizophrenic observers.

24 Oct 2005

Atypical antipsychotic drugs slightly increase risk for death when used in people with dementia

Atypical antipsychotic drugs seem to confer a small increased risk for death when used in people with dementia, concludes a team of researchers from the Keck School of Medicine of the University of Southern California in a meta-analysis of 15 clinical trials published in the October 19 issue of the JAMA: The Journal of the American Medical Association.

18 Oct 2005

Parkinson's dark period can be minimized or alleviated with the right kind of care

Some people call it "the dark time," the period between when a person is diagnosed with Parkinson's disease and when treatment with medication begins.

26 Sep 2005

New study details side effects of five medications that are currently used to treat people with schizophrenia

A large study funded by NIH's National Institute of Mental Health (NIMH) provides, for the first time, detailed information comparing the effectiveness and side effects of five medications - both new and older medications - that are currently used to treat people with schizophrenia.

21 Sep 2005

Greater public awareness needed after death of woman from rabies

Scientists in the UK who have been looking into the death of a British woman from rabies are now demanding greater public awareness of the very real dangers posed by the infection.

5 Sep 2005

Depressant benzodiazepine especially effective at treating seizure in alcohol withdrawal syndrome patients

Tranquilizers work better than placebos at treating the symptoms of alcohol withdrawal syndrome but they may not work better than other drugs, according to a new review of recent studies.

29 Aug 2005